vs
MEDIFAST INC（MED）与味好美（MKC）财务数据对比。点击上方公司名可切换其他公司
味好美的季度营收约是MEDIFAST INC的24.6倍（$1.9B vs $75.1M）。味好美同比增速更快（2.9% vs -36.9%）。过去两年味好美的营收复合增速更高（7.5% vs -34.4%）
迈德福斯特是一家总部位于美国马里兰州巴尔的摩的营养减重企业，该公司研发、分销并销售减重及健康相关产品，销售渠道涵盖官方网站、多层次营销、电话销售以及品牌加盟减重诊所。
味好美是美国知名食品企业，专业生产、营销并配送香辛料、复合调味料、调味酱及各类风味产品，客户覆盖零售终端、食品生产商及餐饮服务企业，是全球领先的风味产品供应商。
MED vs MKC — 直观对比
营收规模更大
MKC
是对方的24.6倍
$75.1M
营收增速更快
MKC
高出39.8%
-36.9%
两年增速更快
MKC
近两年复合增速
-34.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $75.1M | $1.9B |
| 净利润 | — | $226.6M |
| 毛利率 | 69.4% | 38.9% |
| 营业利润率 | -10.4% | 16.8% |
| 净利率 | — | 12.2% |
| 营收同比 | -36.9% | 2.9% |
| 净利润同比 | — | 5.3% |
| 每股收益（稀释后） | $-1.64 | $0.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MEDMKC
| Q4 25 | $75.1M | $1.9B | ||
| Q3 25 | $89.4M | $1.7B | ||
| Q2 25 | $105.6M | $1.7B | ||
| Q1 25 | $115.7M | $1.6B | ||
| Q4 24 | $119.0M | $1.8B | ||
| Q3 24 | $140.2M | $1.7B | ||
| Q2 24 | $168.6M | $1.6B | ||
| Q1 24 | $174.7M | $1.6B |
净利润MEDMKC
| Q4 25 | — | $226.6M | ||
| Q3 25 | $-2.3M | $225.5M | ||
| Q2 25 | $2.5M | $175.0M | ||
| Q1 25 | $-772.0K | $162.3M | ||
| Q4 24 | — | $215.2M | ||
| Q3 24 | $1.1M | $223.1M | ||
| Q2 24 | $-8.2M | $184.2M | ||
| Q1 24 | $8.3M | $166.0M |
毛利率MEDMKC
| Q4 25 | 69.4% | 38.9% | ||
| Q3 25 | 69.5% | 37.4% | ||
| Q2 25 | 72.6% | 37.5% | ||
| Q1 25 | 72.8% | 37.6% | ||
| Q4 24 | 74.1% | 40.2% | ||
| Q3 24 | 75.4% | 38.7% | ||
| Q2 24 | 73.2% | 37.7% | ||
| Q1 24 | 72.8% | 37.4% |
营业利润率MEDMKC
| Q4 25 | -10.4% | 16.8% | ||
| Q3 25 | -4.6% | 16.7% | ||
| Q2 25 | -1.0% | 14.8% | ||
| Q1 25 | -1.1% | 14.0% | ||
| Q4 24 | 0.6% | 17.0% | ||
| Q3 24 | 1.5% | 17.1% | ||
| Q2 24 | -4.7% | 14.2% | ||
| Q1 24 | 4.5% | 14.6% |
净利率MEDMKC
| Q4 25 | — | 12.2% | ||
| Q3 25 | -2.5% | 13.1% | ||
| Q2 25 | 2.3% | 10.5% | ||
| Q1 25 | -0.7% | 10.1% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | 0.8% | 13.3% | ||
| Q2 24 | -4.8% | 11.2% | ||
| Q1 24 | 4.8% | 10.4% |
每股收益（稀释后）MEDMKC
| Q4 25 | $-1.64 | $0.84 | ||
| Q3 25 | $-0.21 | $0.84 | ||
| Q2 25 | $0.22 | $0.65 | ||
| Q1 25 | $-0.07 | $0.60 | ||
| Q4 24 | $0.08 | $0.79 | ||
| Q3 24 | $0.10 | $0.83 | ||
| Q2 24 | $-0.75 | $0.68 | ||
| Q1 24 | $0.76 | $0.62 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.3M | $95.9M |
| 总债务越低越好 | — | $3.6B |
| 股东权益账面价值 | $198.9M | $5.7B |
| 总资产 | $248.0M | $13.2B |
| 负债/权益比越低杠杆越低 | — | 0.63× |
8季度趋势，按日历期对齐
现金及短期投资MEDMKC
| Q4 25 | $167.3M | $95.9M | ||
| Q3 25 | $173.5M | $94.9M | ||
| Q2 25 | $162.7M | $124.1M | ||
| Q1 25 | $164.6M | $102.8M | ||
| Q4 24 | $162.3M | $186.1M | ||
| Q3 24 | $170.0M | $200.8M | ||
| Q2 24 | $163.5M | $166.3M | ||
| Q1 24 | $156.4M | $178.0M |
总债务MEDMKC
| Q4 25 | — | $3.6B | ||
| Q3 25 | — | $3.9B | ||
| Q2 25 | — | $3.9B | ||
| Q1 25 | — | $3.9B | ||
| Q4 24 | — | $3.9B | ||
| Q3 24 | — | $3.4B | ||
| Q2 24 | — | $4.1B | ||
| Q1 24 | — | $4.1B |
股东权益MEDMKC
| Q4 25 | $198.9M | $5.7B | ||
| Q3 25 | $214.7M | $5.8B | ||
| Q2 25 | $216.0M | $5.6B | ||
| Q1 25 | $211.0M | $5.4B | ||
| Q4 24 | $210.1M | $5.3B | ||
| Q3 24 | $207.3M | $5.4B | ||
| Q2 24 | $205.3M | $5.3B | ||
| Q1 24 | $211.0M | $5.2B |
总资产MEDMKC
| Q4 25 | $248.0M | $13.2B | ||
| Q3 25 | $268.2M | $13.2B | ||
| Q2 25 | $269.3M | $13.2B | ||
| Q1 25 | $280.0M | $12.9B | ||
| Q4 24 | $284.2M | $13.1B | ||
| Q3 24 | $291.2M | $13.2B | ||
| Q2 24 | $293.5M | $13.0B | ||
| Q1 24 | $302.8M | $12.9B |
负债/权益比MEDMKC
| Q4 25 | — | 0.63× | ||
| Q3 25 | — | 0.67× | ||
| Q2 25 | — | 0.69× | ||
| Q1 25 | — | 0.71× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 0.79× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.3M | $542.0M |
| 自由现金流经营现金流 - 资本支出 | $-6.6M | — |
| 自由现金流率自由现金流/营收 | -8.8% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | — | 2.39× |
| 过去12个月自由现金流最近4个季度 | $1.2M | — |
8季度趋势，按日历期对齐
经营现金流MEDMKC
| Q4 25 | $-5.3M | $542.0M | ||
| Q3 25 | $12.1M | $258.8M | ||
| Q2 25 | $-3.4M | $45.9M | ||
| Q1 25 | $3.4M | $115.5M | ||
| Q4 24 | $-4.9M | $458.7M | ||
| Q3 24 | $9.1M | $161.7M | ||
| Q2 24 | $13.1M | $163.1M | ||
| Q1 24 | $7.3M | $138.4M |
自由现金流MEDMKC
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $10.8M | $206.1M | ||
| Q2 25 | $-4.8M | $-2.4M | ||
| Q1 25 | $1.9M | $78.4M | ||
| Q4 24 | $-7.2M | — | ||
| Q3 24 | $7.7M | $102.7M | ||
| Q2 24 | $11.1M | $94.8M | ||
| Q1 24 | $5.4M | $76.4M |
自由现金流率MEDMKC
| Q4 25 | -8.8% | — | ||
| Q3 25 | 12.0% | 11.9% | ||
| Q2 25 | -4.5% | -0.1% | ||
| Q1 25 | 1.6% | 4.9% | ||
| Q4 24 | -6.1% | — | ||
| Q3 24 | 5.5% | 6.1% | ||
| Q2 24 | 6.6% | 5.8% | ||
| Q1 24 | 3.1% | 4.8% |
资本支出强度MEDMKC
| Q4 25 | 1.8% | — | ||
| Q3 25 | 1.5% | 3.1% | ||
| Q2 25 | 1.3% | 2.9% | ||
| Q1 25 | 1.3% | 2.3% | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.0% | 3.5% | ||
| Q2 24 | 1.1% | 4.2% | ||
| Q1 24 | 1.1% | 3.9% |
现金转化率MEDMKC
| Q4 25 | — | 2.39× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | -1.36× | 0.26× | ||
| Q1 25 | — | 0.71× | ||
| Q4 24 | — | 2.13× | ||
| Q3 24 | 8.04× | 0.72× | ||
| Q2 24 | — | 0.89× | ||
| Q1 24 | 0.88× | 0.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MED
暂无分部数据
MKC
| Consumer | $1.1B | 61% |
| Flavor Solutions | $723.1M | 39% |
